Without a Ribbon
  • About
    • Events
    • Get In Touch
  • Rare Cancer Resources
  • Shop
  • How You Can Help
  • Meet Warriors
  • News
  • Login
  • Register

Select Page

HELP

LEARN

EVENTS

# et-post-format-video

Methotrexate-Associated Lymphoproliferative Disorder – Symptoms, Treatment & Support

What is Methotrexate-Associated Lymphoproliferative Disorder? The methotrexate-associated lymphoproliferative disease is a non-malignant rapid division or proliferation of lymphocytes (white blood cells) producing tissues or organs in patients taking methotrexate....

Familial Adenomatous Polyposis and Desmoids Disease – Symptoms, Treatment & Support

What are Familial Adenomatous Polyposis and Desmoids Disease? Familial adenomatous polyposis is an inherited disorder characterized by the development of several benign abnormal tissue growths called adenomatous polyps, which originate from the glandular epithelial...

Dedifferentiated Liposarcoma – Symptoms, Treatment & Support

What is Liposarcoma? It is a rare type of cancer that originates from the fat cells or tissues of the body. The most common sites of its origination are the thighs and retroperitoneum (abdominal cavity/space behind the peritoneum) of the abdomen; however, it can...

Alveolar Soft part Sarcoma – Symptoms, Treatment & Support

What is alveolar soft part sarcoma? Alveolar soft tissue sarcoma is a slowly growing soft tissue tumour that can originate from a variety of soft tissues such as muscle, fat, and nerves. It especially affects young people and has a poor prognosis. It is usually...

Alpha Heavy Chain Disease

What is an Alpha Heavy Chain Disease? Alpha heavy chain disease is a plasma cell cancer characterized by incomplete production of antibodies with overproduction of heavy chains without associated light chains. The clinical characteristics of the disease are diarrhoea...
Older Entries
Next Entries

If you need any help or advice just

Get In Touch

© Without a Ribbon 2019. All rights reserved.Powered by WEB 105 Creative

Stay up to date.

Sign up to our newsletter